Objective: To assess if ezetimibe (EZE), a sterol-absorption inhibitor, improves platelet (PLT) count and size relative to its effect on plasma plant sterol (PS) in patients with sitosterolemia (STSL). Study design: Patients with STSL (5 males, 3 females, 16-56 years of age) receiving EZE intervention as part of their routine care participated in this study. EZE was discontinued for 14 weeks (off) and then resumed for another 14 weeks (on). Hematology variables along with plasma and red blood cells (RBC) PS and total cholesterol (TC) levels were measured at the end of each phase. Results: EZE increased PLT count (23% ± 9%) and decreased mean PLT volume (MPV; 10% ± 3%, all P < .05). In patients off EZE, PLT counts inversely correlated (r = -0.96 and r = -0.91, all P
CITATION STYLE
Othman, R. A., Myrie, S. B., Mymin, D., Merkens, L. S., Roullet, J. B., Steiner, R. D., & Jones, P. J. H. (2015). Ezetimibe reduces plant sterol accumulation and favorably increases platelet count in sitosterolemia. Journal of Pediatrics, 166(1), 125–131. https://doi.org/10.1016/j.jpeds.2014.08.069
Mendeley helps you to discover research relevant for your work.